A Study of Enzastaurin in Participants With Follicular Lymphoma

Clinical trial NCT00475644 · COMPLETED

Trial details

NCT number: NCT00475644
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Lymphoma, Follicular

Start date: 2007-05-01
Primary completion: 2012-04-01
Enrollment: 66

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.